Effect of Lockdown and Mass Testing for the SARS-CoV-2 Omicron Epidemic on Reducing New Infections in Shenzhen, China

被引:3
|
作者
Han, Xinxin [1 ]
Li, Xiaotong [1 ,2 ]
Zhu, Bin [1 ]
Zhao, Wenjing [1 ]
Huang, Jie [1 ]
Liu, Gang [3 ]
Gu, Dongfeng [1 ]
机构
[1] Southern Univ Sci & Technol, Sch Publ Hlth & Emergency Management, Shenzhen 518055, Peoples R China
[2] Hong Kong Univ Sci & Technol, Div Publ Policy, Hong Kong, Peoples R China
[3] Shenzhen Ctr Dis Prevent & Control, Shenzhen 518020, Peoples R China
关键词
lockdown; infections; omicron epidemic; asymptomatic cases;
D O I
10.3390/healthcare10091725
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
On 14 March 2022, China's tech hub Shenzhen, a mega-city with more than 18 million inhabitants, imposed a one-week citywide lockdown immediately after it observed a surge in infections. We assessed the effect of this one-week lockdown, coupled with mass testing, on reducing the daily number of new confirmed cases and asymptomatic cases during the Omicron wave, using an interrupted time series analysis approach. Our analysis suggests that the one-week citywide lockdown in Shenzhen was effective at lowering both daily new confirmed cases and asymptomatic cases during the Omicron wave. Early detection ensures timely isolation and treatment of infected patients in designated hospitals, and therefore helps lower the prevalence of confirmed cases and asymptomatic cases. Our findings of the immediate increase in asymptomatic cases after lockdown warrant further verifications in other city epidemic scenarios.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT
    Sigal, Alex
    Milo, Ron
    Jassat, Waasila
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (05) : 267 - 269
  • [32] Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
    Sophia T. Tan
    Ada T. Kwan
    Isabel Rodríguez-Barraquer
    Benjamin J. Singer
    Hailey J. Park
    Joseph A. Lewnard
    David Sears
    Nathan C. Lo
    Nature Medicine, 2023, 29 : 358 - 365
  • [33] Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
    Bolze, Alexandre
    Basler, Tracy
    White, Simon
    Dei Rossi, Andrew
    Wyman, Dana
    Dai, Hang
    Stous, Sarah
    Roychoudhury, Pavitra
    Greninger, Alexander L.
    Hayashibara, Kathleen
    Beatty, Mark
    Shah, Seema
    Stous, Sarah
    McCrone, John T.
    Kil, Eric
    Cassens, Tyler
    Tsan, Kevin
    Nguyen, Jason
    Ramirez, Jimmy
    Carter, Scotty
    Cirulli, Elizabeth T.
    Barrett, Kelly Schiabor
    Washington, Nicole L.
    Belda-Ferre, Pedro
    Jacobs, Sharoni
    Sandoval, Efren
    Becker, David
    Lu, James T.
    Isaksson, Magnus
    Lee, William
    Luo, Shishi
    MED, 2022, 3 (12): : 848 - +
  • [34] Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
    Marzia Cavalli
    Giulia Campoli
    Anna Anselmo
    Rossella Brandi
    Antonella Fortunato
    Maria Di Spirito
    Anella Monte
    Martina Lipari
    Manfredo Bortone
    Vanessa Vera Fain
    Raffaele D’Amelio
    Florigio Lista
    Silvia Fillo
    Scientific Reports, 15 (1)
  • [35] Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
    Tan, Sophia T.
    Kwan, Ada T.
    Rodriguez-Barraquer, Isabel
    Singer, Benjamin J.
    Park, Hailey J.
    Lewnard, Joseph A.
    Sears, David
    Lo, Nathan C.
    NATURE MEDICINE, 2023, 29 (02) : 358 - 365
  • [36] Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China
    He, Xiaofeng
    Liao, Yuxue
    Liang, Yuanhao
    Yu, Jiexin
    Gao, Wei
    Wan, Jia
    Liao, Yi
    Su, Jiao
    Zou, Xuan
    Tang, Shixing
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [37] Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
    Paul Elliott
    Oliver Eales
    Barbara Bodinier
    David Tang
    Haowei Wang
    Jakob Jonnerby
    David Haw
    Joshua Elliott
    Matthew Whitaker
    Caroline E. Walters
    Christina Atchison
    Peter J. Diggle
    Andrew J. Page
    Alexander J. Trotter
    Deborah Ashby
    Wendy Barclay
    Graham Taylor
    Helen Ward
    Ara Darzi
    Graham S. Cooke
    Marc Chadeau-Hyam
    Christl A. Donnelly
    Nature Communications, 13
  • [38] Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
    Elliott, Paul
    Eales, Oliver
    Bodinier, Barbara
    Tang, David
    Wang, Haowei
    Jonnerby, Jakob
    Haw, David
    Elliott, Joshua
    Whitaker, Matthew
    Walters, Caroline E.
    Atchison, Christina
    Diggle, Peter J.
    Page, Andrew J.
    Trotter, Alexander J.
    Ashby, Deborah
    Barclay, Wendy
    Taylor, Graham
    Ward, Helen
    Darzi, Ara
    Cooke, Graham S.
    Chadeau-Hyam, Marc
    Donnelly, Christl A.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [39] Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines
    Li, Yao-Tsun
    Polotan, Francisco Gerardo M.
    Sotelo, Gerald Ivan S.
    Alpino, Anne Pauline A.
    Dolor, Ardiane Ysabelle M.
    Tujan, Ma Angelica A.
    Gomez, Ma Ricci R.
    Onza, Othoniel Jan T.
    Chang, Angela Kae T.
    Bautista, Criselda T.
    Carandang, June C.
    Yangzon, Maria Sofia L.
    Pangilinan, Elcid Aaron R.
    Mantaring, Renato Jacinto
    Telles, Alyssa Joyce E.
    Egana, John Michael C.
    Endozo, Joshua Jose S.
    Cruz, Rianna Patricia S.
    Tablizo, Francis A.
    Yap, Jan Michael C.
    Maralit, Benedict A.
    Ayes, Marc Edsel C.
    de la Paz, Eva Marie C.
    Saloma, Cynthia P.
    Lim, Dodge R.
    Dancel, Lei Lanna M.
    Uy-Lumandas, Mayan
    Medado, Inez Andrea P.
    Dizon, Timothy John R.
    Hampson, Katie
    Daldry, Simon
    Hughes, Joseph
    Brunker, Kirstyn
    VIRUS EVOLUTION, 2022, 8 (02)
  • [40] The value of serology testing to manage SARS-CoV-2 infections
    Fernandez-Barat, Laia
    Lopez-Aladid, Ruben
    Torres, Antoni
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)